FDA Inspection 1025379 — Dr. Ewa Smukalska
The FDA completed an inspection of Dr. Ewa Smukalska on August 18, 2017 in Bydgoszcz. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 18, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Bydgoszcz (Poland)
Additional Details
Clinical Investigator (CI)